Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ppara
|
ENSMUSG00000022383.7 | peroxisome proliferator activated receptor alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_85773217_85773402 | Ppara | 1095 | 0.439403 | -0.41 | 1.1e-03 | Click! |
chr15_85773920_85774071 | Ppara | 1781 | 0.286936 | -0.37 | 3.7e-03 | Click! |
chr15_85737139_85737438 | Ppara | 1157 | 0.411315 | -0.36 | 4.3e-03 | Click! |
chr15_85737455_85737606 | Ppara | 1399 | 0.347165 | -0.33 | 1.1e-02 | Click! |
chr15_85743824_85743975 | Ppara | 7768 | 0.149321 | -0.27 | 3.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_170674573_170675954 | 9.59 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr15_76519928_76521866 | 6.08 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr7_141428600_141429722 | 5.22 |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
190 |
0.82 |
chr4_129226645_129228191 | 5.15 |
C77080 |
expressed sequence C77080 |
62 |
0.96 |
chr13_83737592_83739114 | 4.76 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr2_170734259_170734932 | 4.58 |
Dok5 |
docking protein 5 |
2788 |
0.35 |
chr3_96181539_96182795 | 4.38 |
Sv2a |
synaptic vesicle glycoprotein 2 a |
1016 |
0.22 |
chr7_79498955_79500626 | 4.17 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr12_88723574_88724074 | 3.91 |
Nrxn3 |
neurexin III |
715 |
0.73 |
chr11_76466993_76468433 | 3.83 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr7_24485614_24487418 | 3.82 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr10_49786487_49786915 | 3.63 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2053 |
0.25 |
chr13_99513882_99514334 | 3.61 |
Map1b |
microtubule-associated protein 1B |
2410 |
0.23 |
chr7_89632223_89633470 | 3.49 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
40 |
0.79 |
chr1_132541040_132543287 | 3.46 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr2_181155937_181157234 | 3.41 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr8_9768980_9769453 | 3.36 |
Fam155a |
family with sequence similarity 155, member A |
888 |
0.47 |
chr7_78575006_78575482 | 3.35 |
Gm39038 |
predicted gene, 39038 |
12 |
0.97 |
chr15_98983254_98984205 | 3.30 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr10_80145023_80147388 | 3.30 |
Midn |
midnolin |
2067 |
0.14 |
chr13_83721518_83722206 | 3.27 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
481 |
0.73 |
chr10_80300884_80302968 | 3.22 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr1_5916517_5917959 | 3.15 |
Npbwr1 |
neuropeptides B/W receptor 1 |
160 |
0.97 |
chr8_95703051_95704038 | 3.08 |
Ndrg4 |
N-myc downstream regulated gene 4 |
474 |
0.68 |
chr1_92849002_92850443 | 3.06 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr10_25458395_25459149 | 3.01 |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
8201 |
0.21 |
chr8_94995811_94996872 | 2.95 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr2_91119045_91119896 | 2.87 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr5_38157284_38157435 | 2.84 |
Nsg1 |
neuron specific gene family member 1 |
1672 |
0.31 |
chr3_28265964_28266166 | 2.83 |
Tnik |
TRAF2 and NCK interacting kinase |
2422 |
0.31 |
chrX_99822549_99823006 | 2.82 |
Tmem28 |
transmembrane protein 28 |
1756 |
0.43 |
chr8_123410787_123412789 | 2.79 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr8_125897868_125898882 | 2.78 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chr2_158606690_158608449 | 2.74 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr2_181313043_181314281 | 2.73 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr10_111249619_111250191 | 2.72 |
Osbpl8 |
oxysterol binding protein-like 8 |
1837 |
0.35 |
chr7_44310203_44311401 | 2.70 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
549 |
0.46 |
chr13_83722679_83723219 | 2.69 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1568 |
0.29 |
chr5_144547334_144548656 | 2.63 |
Nptx2 |
neuronal pentraxin 2 |
2093 |
0.41 |
chrX_66649259_66650015 | 2.58 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
319 |
0.89 |
chr15_85679298_85680211 | 2.57 |
Lncppara |
long noncoding RNA near Ppara |
24019 |
0.12 |
chr10_112271302_112272238 | 2.55 |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
649 |
0.75 |
chr5_103209022_103210413 | 2.55 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr2_6883618_6884699 | 2.51 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr5_88584955_88585475 | 2.50 |
Rufy3 |
RUN and FYVE domain containing 3 |
1421 |
0.37 |
chr5_134101487_134102203 | 2.49 |
Castor2 |
cytosolic arginine sensor for mTORC1 subunit 2 |
1840 |
0.26 |
chr13_20473087_20474265 | 2.49 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr1_115686481_115687365 | 2.49 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr2_65563921_65564380 | 2.48 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
3342 |
0.29 |
chr6_122741558_122742751 | 2.47 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
108 |
0.95 |
chr13_36729599_36730738 | 2.46 |
Nrn1 |
neuritin 1 |
500 |
0.75 |
chr19_8838893_8839483 | 2.44 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr1_42703141_42704653 | 2.43 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr7_99539267_99540357 | 2.42 |
Arrb1 |
arrestin, beta 1 |
143 |
0.93 |
chr13_54191853_54192989 | 2.38 |
Hrh2 |
histamine receptor H2 |
292 |
0.9 |
chrX_88113433_88114223 | 2.38 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1817 |
0.46 |
chr7_79500711_79501247 | 2.38 |
Mir9-3hg |
Mir9-3 host gene |
858 |
0.39 |
chr13_18948406_18949248 | 2.38 |
Amph |
amphiphysin |
429 |
0.8 |
chr9_121299469_121300553 | 2.37 |
Trak1 |
trafficking protein, kinesin binding 1 |
2182 |
0.23 |
chr14_25610327_25611867 | 2.34 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chr12_86680036_86680970 | 2.34 |
Vash1 |
vasohibin 1 |
1803 |
0.28 |
chr2_181715341_181715994 | 2.34 |
Oprl1 |
opioid receptor-like 1 |
35 |
0.95 |
chr2_14740186_14740953 | 2.33 |
Gm10848 |
predicted gene 10848 |
847 |
0.36 |
chr8_47284401_47285223 | 2.32 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr3_4799014_4799414 | 2.32 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
279 |
0.93 |
chr13_105249326_105250833 | 2.32 |
Rnf180 |
ring finger protein 180 |
20960 |
0.22 |
chr12_108605770_108606876 | 2.31 |
Evl |
Ena-vasodilator stimulated phosphoprotein |
557 |
0.74 |
chr5_135806693_135807939 | 2.30 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chr6_39875361_39875680 | 2.30 |
Tmem178b |
transmembrane protein 178B |
2449 |
0.23 |
chr10_69536011_69536410 | 2.30 |
Ank3 |
ankyrin 3, epithelial |
1988 |
0.39 |
chr7_140080531_140082545 | 2.29 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr11_6604576_6606131 | 2.29 |
Nacad |
NAC alpha domain containing |
700 |
0.46 |
chr9_124441736_124442440 | 2.29 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
658 |
0.65 |
chr16_88287797_88287976 | 2.28 |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
1845 |
0.43 |
chr6_136167149_136168437 | 2.28 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
4096 |
0.25 |
chr10_89256685_89257951 | 2.28 |
Ano4 |
anoctamin 4 |
18 |
0.99 |
chr10_127080770_127082245 | 2.27 |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
2600 |
0.11 |
chr6_114130915_114132167 | 2.26 |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
122 |
0.97 |
chr5_112227269_112228017 | 2.25 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
998 |
0.41 |
chr4_82509049_82510307 | 2.24 |
Gm11266 |
predicted gene 11266 |
1662 |
0.38 |
chr4_97786641_97786834 | 2.24 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
8659 |
0.21 |
chr18_61012428_61012840 | 2.23 |
Slc6a7 |
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 |
1572 |
0.3 |
chr10_81229656_81230911 | 2.21 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chrX_170677021_170677569 | 2.21 |
Asmt |
acetylserotonin O-methyltransferase |
4651 |
0.33 |
chr17_56472644_56474083 | 2.20 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1264 |
0.39 |
chrX_134295383_134296942 | 2.20 |
Tmem35a |
transmembrane protein 35A |
937 |
0.52 |
chr16_43505394_43505961 | 2.19 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1980 |
0.41 |
chr12_72234504_72235243 | 2.19 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr6_82091782_82092469 | 2.18 |
Gm15864 |
predicted gene 15864 |
39544 |
0.14 |
chr1_143642293_143642622 | 2.17 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
68 |
0.97 |
chr15_82277282_82277951 | 2.16 |
Septin3 |
septin 3 |
2216 |
0.14 |
chr14_122483877_122484540 | 2.15 |
Zic2 |
zinc finger protein of the cerebellum 2 |
6108 |
0.11 |
chr2_158609356_158610186 | 2.14 |
Gm14204 |
predicted gene 14204 |
819 |
0.36 |
chr5_111424407_111425623 | 2.13 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr1_173365727_173366467 | 2.12 |
Cadm3 |
cell adhesion molecule 3 |
1536 |
0.34 |
chr8_94995272_94995731 | 2.12 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
160 |
0.93 |
chr8_12926230_12928559 | 2.12 |
Mcf2l |
mcf.2 transforming sequence-like |
762 |
0.52 |
chr5_88583963_88584847 | 2.09 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr4_42951254_42951979 | 2.08 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
1176 |
0.34 |
chr2_158610228_158611991 | 2.08 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr12_119945587_119946924 | 2.07 |
Tmem196 |
transmembrane protein 196 |
155 |
0.95 |
chr15_86028772_86030702 | 2.06 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
4466 |
0.22 |
chr18_25750468_25751272 | 2.05 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr1_62709496_62710533 | 2.05 |
Nrp2 |
neuropilin 2 |
6312 |
0.18 |
chr10_69536775_69537233 | 2.04 |
Ank3 |
ankyrin 3, epithelial |
2782 |
0.32 |
chr4_91373231_91373407 | 2.04 |
Mir6402 |
microRNA 6402 |
44 |
0.8 |
chr2_32095529_32096644 | 2.03 |
Plpp7 |
phospholipid phosphatase 7 (inactive) |
69 |
0.95 |
chr18_77562763_77562968 | 2.02 |
Rnf165 |
ring finger protein 165 |
1744 |
0.41 |
chr13_105444000_105445296 | 2.02 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr13_83741336_83742027 | 2.02 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2818 |
0.16 |
chr3_67553320_67553471 | 2.01 |
Gm35299 |
predicted gene, 35299 |
30 |
0.96 |
chr7_46399823_46400899 | 2.01 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
2713 |
0.23 |
chr10_110454344_110454630 | 2.01 |
Nav3 |
neuron navigator 3 |
1717 |
0.42 |
chr4_138251495_138252773 | 2.00 |
Sh2d5 |
SH2 domain containing 5 |
1670 |
0.22 |
chr7_79507205_79507895 | 2.00 |
Mir9-3 |
microRNA 9-3 |
2286 |
0.14 |
chr7_127017759_127019737 | 2.00 |
Prrt2 |
proline-rich transmembrane protein 2 |
847 |
0.23 |
chrX_166346941_166347276 | 2.00 |
Gpm6b |
glycoprotein m6b |
2266 |
0.36 |
chr16_5884597_5886147 | 1.99 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr3_17789318_17789657 | 1.99 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
434 |
0.83 |
chr8_124795343_124796098 | 1.99 |
Trim67 |
tripartite motif-containing 67 |
2628 |
0.18 |
chr12_15811126_15812067 | 1.97 |
Trib2 |
tribbles pseudokinase 2 |
5189 |
0.17 |
chr5_112225574_112226319 | 1.96 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
2695 |
0.17 |
chr5_110545528_110545748 | 1.95 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
1283 |
0.39 |
chr15_82255980_82257145 | 1.94 |
1500009C09Rik |
RIKEN cDNA 1500009C09 gene |
539 |
0.56 |
chr3_84303363_84303817 | 1.94 |
Trim2 |
tripartite motif-containing 2 |
1151 |
0.59 |
chr18_24711119_24711270 | 1.93 |
Fhod3 |
formin homology 2 domain containing 3 |
1749 |
0.28 |
chr7_99270744_99271357 | 1.92 |
Map6 |
microtubule-associated protein 6 |
1918 |
0.23 |
chr11_3368719_3370424 | 1.92 |
Limk2 |
LIM motif-containing protein kinase 2 |
409 |
0.76 |
chr2_13129875_13130250 | 1.91 |
Gm38156 |
predicted gene, 38156 |
11627 |
0.19 |
chr7_79505833_79506958 | 1.91 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr3_87999404_88000408 | 1.90 |
Bcan |
brevican |
272 |
0.82 |
chr11_30265934_30266417 | 1.90 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
1039 |
0.45 |
chr9_42121573_42122781 | 1.90 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
2120 |
0.33 |
chr2_121295003_121295302 | 1.90 |
Map1a |
microtubule-associated protein 1 A |
302 |
0.75 |
chr5_107498769_107499247 | 1.89 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr6_13835523_13837039 | 1.89 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr4_43406531_43407612 | 1.89 |
Rusc2 |
RUN and SH3 domain containing 2 |
258 |
0.87 |
chr6_120490913_120491429 | 1.89 |
Tmem121b |
transmembrane protein 121B |
2636 |
0.19 |
chr5_116590520_116593206 | 1.89 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr3_31902373_31903967 | 1.88 |
Kcnmb2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
467 |
0.88 |
chr15_25713605_25714406 | 1.88 |
Myo10 |
myosin X |
134 |
0.97 |
chr7_25004827_25006284 | 1.87 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr2_25264308_25268001 | 1.86 |
Tprn |
taperin |
1410 |
0.14 |
chr17_57769126_57770140 | 1.86 |
Cntnap5c |
contactin associated protein-like 5C |
63 |
0.97 |
chr8_34813963_34814958 | 1.85 |
Dusp4 |
dual specificity phosphatase 4 |
7163 |
0.22 |
chr1_159524626_159524870 | 1.85 |
Tnr |
tenascin R |
907 |
0.65 |
chr7_46396141_46398423 | 1.85 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
366 |
0.84 |
chr7_99272446_99273539 | 1.85 |
Map6 |
microtubule-associated protein 6 |
3860 |
0.15 |
chr2_143547529_143548278 | 1.83 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
66 |
0.97 |
chr16_39986641_39987192 | 1.83 |
Lsamp |
limbic system-associated membrane protein |
2321 |
0.41 |
chr18_16805598_16806159 | 1.83 |
Cdh2 |
cadherin 2 |
2584 |
0.29 |
chrX_143929366_143930062 | 1.83 |
Dcx |
doublecortin |
3336 |
0.34 |
chr15_87626925_87627959 | 1.82 |
Tafa5 |
TAFA chemokine like family member 5 |
2212 |
0.46 |
chr1_84693950_84694415 | 1.82 |
Mir5126 |
microRNA 5126 |
1657 |
0.28 |
chr9_21196536_21198489 | 1.82 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr2_121803809_121804141 | 1.81 |
Frmd5 |
FERM domain containing 5 |
2897 |
0.26 |
chrX_162025397_162025772 | 1.80 |
Gm26317 |
predicted gene, 26317 |
43873 |
0.17 |
chr4_46202294_46203178 | 1.80 |
Xpa |
xeroderma pigmentosum, complementation group A |
6425 |
0.17 |
chr15_81936444_81938042 | 1.80 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chr16_6841576_6842071 | 1.79 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
32601 |
0.26 |
chr2_180895307_180895458 | 1.79 |
Gm27032 |
predicted gene, 27032 |
1277 |
0.23 |
chr2_32625425_32626446 | 1.79 |
Ak1 |
adenylate kinase 1 |
497 |
0.58 |
chr4_109155589_109157355 | 1.79 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr17_26416022_26416419 | 1.79 |
Neurl1b |
neuralized E3 ubiquitin protein ligase 1B |
1255 |
0.39 |
chr15_84104886_84106159 | 1.78 |
Sult4a1 |
sulfotransferase family 4A, member 1 |
87 |
0.93 |
chr6_48537635_48538183 | 1.78 |
Atp6v0e2 |
ATPase, H+ transporting, lysosomal V0 subunit E2 |
244 |
0.61 |
chr4_22480645_22481269 | 1.78 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
7409 |
0.17 |
chr5_98180058_98181966 | 1.77 |
Prdm8 |
PR domain containing 8 |
34 |
0.97 |
chr1_194622071_194623282 | 1.76 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr12_102555272_102555761 | 1.76 |
Chga |
chromogranin A |
530 |
0.74 |
chr7_49249866_49250164 | 1.75 |
Nav2 |
neuron navigator 2 |
3170 |
0.3 |
chr7_51624664_51625766 | 1.75 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
67 |
0.98 |
chr10_127261534_127261755 | 1.75 |
Kif5a |
kinesin family member 5A |
1436 |
0.2 |
chr2_25242509_25243012 | 1.75 |
Rnf208 |
ring finger protein 208 |
169 |
0.6 |
chr7_105785466_105785617 | 1.74 |
Dchs1 |
dachsous cadherin related 1 |
2011 |
0.18 |
chrX_161719845_161720465 | 1.73 |
Rai2 |
retinoic acid induced 2 |
2528 |
0.41 |
chr11_74589375_74590721 | 1.73 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
76 |
0.97 |
chr3_68572046_68573169 | 1.73 |
Schip1 |
schwannomin interacting protein 1 |
362 |
0.89 |
chr7_87585368_87585534 | 1.73 |
Grm5 |
glutamate receptor, metabotropic 5 |
1053 |
0.67 |
chr15_94197097_94197248 | 1.72 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
207086 |
0.02 |
chr2_143546820_143547517 | 1.72 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
669 |
0.53 |
chr14_100374663_100375528 | 1.72 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr2_152080491_152081480 | 1.71 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr10_69708232_69708450 | 1.71 |
Ank3 |
ankyrin 3, epithelial |
1863 |
0.49 |
chr5_108549212_108550612 | 1.71 |
Cplx1 |
complexin 1 |
88 |
0.95 |
chr10_128381063_128381470 | 1.71 |
Mir6914 |
microRNA 6914 |
1572 |
0.14 |
chr5_34182980_34183403 | 1.71 |
Mxd4 |
Max dimerization protein 4 |
1179 |
0.3 |
chr5_135248496_135249658 | 1.69 |
Fzd9 |
frizzled class receptor 9 |
2153 |
0.21 |
chr6_37299209_37299387 | 1.69 |
Dgki |
diacylglycerol kinase, iota |
339 |
0.92 |
chr7_46399032_46399239 | 1.69 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
1487 |
0.35 |
chr5_5264770_5266186 | 1.69 |
Cdk14 |
cyclin-dependent kinase 14 |
169 |
0.96 |
chr14_34822420_34823516 | 1.67 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
2860 |
0.27 |
chr16_18129524_18129878 | 1.67 |
Rtn4r |
reticulon 4 receptor |
2059 |
0.22 |
chr7_4119233_4120703 | 1.67 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr2_66408526_66409644 | 1.66 |
Gm13630 |
predicted gene 13630 |
409 |
0.72 |
chr19_37172057_37172442 | 1.66 |
A330032B11Rik |
RIKEN cDNA A330032B11 gene |
1594 |
0.25 |
chr15_82274668_82274868 | 1.65 |
Septin3 |
septin 3 |
125 |
0.91 |
chr7_44973695_44975193 | 1.65 |
Cpt1c |
carnitine palmitoyltransferase 1c |
331 |
0.61 |
chr4_42953037_42954334 | 1.65 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
591 |
0.62 |
chr16_18129282_18129433 | 1.64 |
Rtn4r |
reticulon 4 receptor |
1715 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.5 | 4.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 3.7 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.1 | 3.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.1 | 4.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.0 | 4.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 3.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.0 | 3.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.9 | 3.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 2.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.9 | 1.8 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.9 | 3.7 | GO:0046959 | habituation(GO:0046959) |
0.8 | 4.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.8 | 2.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.8 | 7.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 2.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 3.9 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.8 | 2.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.8 | 5.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 1.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 2.1 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.7 | 6.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.0 | GO:0021586 | pons maturation(GO:0021586) |
0.7 | 2.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 1.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.6 | 1.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.6 | 1.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 3.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.6 | 0.6 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.6 | 1.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 4.0 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.6 | 1.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.6 | 11.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.6 | 2.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 1.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.6 | 5.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.6 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 2.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 2.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 2.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 2.6 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 3.0 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 1.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 4.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.5 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 2.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 1.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 1.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 3.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 4.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.5 | 2.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 3.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 4.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 3.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 3.5 | GO:0015816 | glycine transport(GO:0015816) |
0.4 | 1.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 2.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 3.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.4 | 1.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 1.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 3.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 0.8 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.4 | 1.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 4.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 3.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 2.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 1.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.4 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 3.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.4 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 1.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 2.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.4 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 1.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 3.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.4 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 6.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.4 | 1.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.8 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 3.6 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.4 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 1.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 1.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.7 | GO:0046958 | nonassociative learning(GO:0046958) |
0.3 | 1.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 1.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 2.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 2.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 3.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 1.3 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.3 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 1.0 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 0.7 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.3 | 1.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 1.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.9 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 0.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.8 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.3 | 0.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 1.8 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 2.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 1.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.3 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.3 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 0.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.3 | 0.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 1.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 0.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 1.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.3 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.8 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.3 | 0.8 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.3 | 0.5 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.7 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 4.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 1.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 2.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 4.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.5 | GO:0098597 | observational learning(GO:0098597) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.4 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 0.9 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 0.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.7 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 3.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 1.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.4 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 3.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 2.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 1.7 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.2 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.2 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 6.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.4 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.2 | 0.8 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.2 | 1.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 1.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 1.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 8.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 2.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 3.7 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.6 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 2.1 | GO:0060384 | innervation(GO:0060384) |
0.2 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 0.8 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.2 | 0.6 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 4.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 1.3 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 2.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.7 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.9 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.2 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.4 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.2 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.2 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 2.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 1.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 0.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 1.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 1.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.2 | 1.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.7 | GO:0042220 | response to cocaine(GO:0042220) |
0.2 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 1.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.8 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.2 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 1.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 1.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.2 | 0.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 2.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 1.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 4.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:1901491 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 1.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 2.9 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 1.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.3 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.1 | 0.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.5 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 2.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 6.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.5 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 1.4 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 3.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 1.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.1 | 6.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.3 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.4 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 5.5 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 6.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 6.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 1.2 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 1.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.3 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 1.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 2.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.2 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.2 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 1.3 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.6 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 0.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.4 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.6 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.3 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 1.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.4 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.0 | 1.3 | GO:1990138 | neuron projection extension(GO:1990138) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.0 | 0.5 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.0 | 0.1 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.8 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.2 | GO:0032634 | interleukin-5 production(GO:0032634) |
0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.5 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.8 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.2 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 0.1 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.2 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0007620 | insemination(GO:0007320) copulation(GO:0007620) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.0 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0032347 | regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.0 | 0.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.0 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.0 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 6.6 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 3.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 2.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 2.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 2.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 11.6 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 2.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 1.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 6.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 6.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 4.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 1.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 2.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 13.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 3.4 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 7.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 2.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 4.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 2.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 1.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.3 | 0.9 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 4.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 2.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.3 | 11.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 10.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 7.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 2.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 26.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 3.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 4.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 2.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 8.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 1.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 12.7 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 7.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 3.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 3.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 9.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 2.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 2.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 2.3 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 4.0 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 12.9 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 21.9 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 3.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 2.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 1.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 4.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 1.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 3.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.0 | 4.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 2.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.9 | 4.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 2.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 4.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 2.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 3.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 1.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 5.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 4.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 1.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 2.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 1.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 7.1 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
0.5 | 1.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 2.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.5 | 1.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 1.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 3.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 3.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 6.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 1.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 4.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 2.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 1.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 4.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 4.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 2.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 3.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 3.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 2.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 4.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 4.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 3.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 9.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 1.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 6.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 2.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 4.7 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 4.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 1.0 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.3 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 4.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 2.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 9.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 2.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.6 | GO:0018575 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 4.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 4.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 3.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 4.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 2.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.7 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 1.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 2.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 2.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 4.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 2.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 1.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.2 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.2 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 4.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 2.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 2.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.9 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 3.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.2 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 5.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 2.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 2.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 2.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 9.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 3.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 5.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 1.9 | GO:0050698 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 2.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 9.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 7.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 1.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 3.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 2.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 4.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 2.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 8.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 6.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 1.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 5.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 4.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 7.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 30.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 3.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 10.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 3.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 3.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 2.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 2.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 3.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 6.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 4.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 1.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 14.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |